Investigators conducted a systematic review and meta-analysis to assess the safety and efficacy of fecal microbiota transplantation for C difficile infection in pediatric patients.
Researchers examined the relationship between the pancreatic microbiome and patient characteristics as well as the duodenal microbiome.
A team of researchers examined the effects on the microbiome from daily long-term consumption of high-protein, drained yogurt in women with overweight and obesity.
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Using a systematic literature review, researchers assessed whether cardiometabolic diseases could be modulated with dietary interventions that affect the gut microbiome.
Investigators assessed whether alterations in gut microbiome composition were linked to postacute COVID-19 syndrome.
Researchers conducted a study to determine whether age-related changes in microbiome composition are associated with an increased susceptibility and risk for COVID-19 infection.
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
Investigators assessed the development and overall characteristics of the gut microbiome in children with autism spectrum disorder.
